Gladden Brian T 4
4 · DENTSPLY SIRONA Inc. · Filed Jun 15, 2026
Research Summary
AI-generated summary of this filing
DENTSPLY SIRONA (XRAY) Director Brian Gladden Buys 9,985 Shares
What Happened
- Brian T. Gladden, a director of DENTSPLY SIRONA Inc. (XRAY), acquired 9,985.022 shares in an open-market purchase on 2026-06-15. The filing reports a weighted-average price of $10.02 per share, for an aggregate cost of roughly $100,000. This was a direct purchase (transaction code P).
Key Details
- Transaction date: 2026-06-15 (Period of Report: 2026-06-15).
- Reported price: weighted average $10.02; footnote states underlying trades ranged from $10.015 to $10.0156.
- Shares acquired: 9,985.022; aggregate reported value ≈ $100,000.
- Shares owned after transaction: not disclosed in the provided filing excerpt.
- Filing timeliness: Period of Report matches the transaction date, so the filing appears timely.
- Footnote: Reporting person offers to provide full breakdown of the number of shares purchased at each price within the reported range upon request.
Context
- This was an open-market purchase by a board director (not an option exercise, award, or gift). Purchases by insiders are often watched by investors as a potential positive signal, but they are one data point and do not alone indicate the company’s prospects.
Insider Transaction Report
Form 4
Gladden Brian T
Director
Transactions
- Purchase
Common Stock
[F1]2026-06-15$10.02/sh+9,985.022$100,000→ 61,848.544 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.015 to 10.0156, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Signature
/s/ Jessica Nielsen Causey, Attorney-in-Fact for Brian T. Gladden|2026-06-15